Abstract
First described by the Austro-Hungarian dermatologist Moritz Kaposi in the last century [1], Kaposi’s sarcoma (KS) was for many years considered a rare, slowly progressive tumour of elderly males of some Mediterranean and Eastern European countries. In this “classical” form of KS, lesions are mainly confined to the skin and localised preferentially on the extremities. In the early 1950s, it was found that KS comprised up to 8% of malignancies in some sub-Saharan regions, in particular in parts of Central Africa, such as Zaire (for a compilation of epidemiological studies, see [2]). This “endemic” form of KS occasionally affects children [3]. KS is also more common among immunosuppressed organ transplant recipients, in particular if they come from countries where other forms of HIV-negative KS are more frequent [4,5]. However, in developed countries KS is now most commonly associated with HIV infection, and this variant, termed “epidemic KS” is characterised by widely distributed lesions, visceral as well as involving lymph nodes, and a rapidly progressive course.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Kaposi, M.: Idiopathisches multiples Pigmentsarkon der Haut, Arch. Dermatol. Syphil 4 (1872), 742–749.
IARC monographs on the evaluation of carcinogenic risks to humans: Human Immunodeficiency Viruses and Human T-cell Lymphotropic Viruses 67 (1996), 76.
Matondo, P. and Zumla, A.: The spectrum of African Kaposi’s sarcoma: is it consequential upon diverse immunological responses?, Scand. J. Infect. Dis 28 (1996), 225–230.
Farge, D.: Kaposi’s sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France, Eur. J. Med 2 (1993), 339–343.
Penn, I.: Kaposi’s sarcoma in transplant recipients, Transplantation 64 (1997), 669–673
Beral, V.: Epidemiology of Kaposi’s sarcoma. In: Cancer, HIV and AIDS, Cancer Surveys (V. Beral, H.W. Jaffe, and R.A. Weiss, eds.), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 10 (1991), pp. 5–22.
Beral, V., Peterman, T. A., Berkelman, R.L. and Jaffe, H.W.: Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection?, Lancet 335 (1990), 123–128.
Beral, V., Bull, D., Jaffe, H., Evans, B., Gill, N., Tillett, H. and Swerdlow, A.J.: Risk of Kaposi’s sarcoma in AIDS patients in the British Isles; is it increased if sexual partners come from the USA or Africa?, Brit. Med. J 324 (1991), 624–625.
Archibald, C.P., Schechter, M.T., Craib, K.J.P. et al.: Risk factors for Kaposi’s sarcoma in the Vancouver lymphadenopathy-AIDS study, J Acq. Immune Def. Syndr. Human Retrovir 3 (suppl. 1) (1990), S18–S23.
Chang, Y., Cesarman, E., Pessin, M.S., Lee, F., Culpepper, J., Knowles, D.M. and Moore, P.S.: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma, Science 266 (1994), 1865–1869.
Schulz, T.F.: Epidemiology of Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV8), Adv. Cancer Res,in press.
Cockerell, C.J.: Histopathological features of Kaposi’s sarcoma in HIV- infected individuals. In: Cancer, HIV and AIDS Beral,V., Jaffe, H.W. and Weiss, R.A., eds.), Cancer Surveys 10 (1991), 39–52.
Roth,W.K., Brandstetter, H. and Stürzl, M.: Cellular and molecular features of HIV-associated Kaposi’s sarcoma, AIDS 6 (1992), 895–913.
Rappersberger, K., Tschachler, E., Zonzit, E. et al.: Endemic Kaposi’s sarcoma in human immunodeficicency virus type I-seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions, J. Invest. Dermatol 95 (1991), 371–381.
Nadji, M., Morales, A.R., Ziegler-Weissman, J., Penneys, N.S.: Kaposi’s sarcoma: immunohistological evidence for an endothelial origin, Arch. Pathol. Lab. Med. 105 (1981), 274–275.
Modlin, R.L., Hofman, F.M., Kempf, R.A., Taylor, C.R., Conant, M.A. and Rea, T.H.: Kaposi’s sarcoma in homosexual men: an immunohistochemical study, J. Am. Acad. Dermatol 8 (1983), 620–627.
Roth, W.K., Werner, S., Risau, W., Remberger, K. and Hofschneider, P.H.: Cultured, AIDS-related Kaposi’s sarcoma cells express endothelial cell markers and are weakly malignant in vitro, Int. J. Cancer 42 (1988), 767–773.
Zhang, Y.-M., Bachmann, S., Hemmer, C., van Lunzen, J., von Stemm, A., Kem, P., Dietrich, M., Ziegler, R., Waldherr, R. and Nawroth, P.P.: Vascular origin of Kaposi’s sarcoma: expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor, Am. J. Pathol 144 (1994), 51–59.
Browning, P.J., Sechler, J.M.G., Kaplan, M., Washington, R.H., Gendelman, R., Yarchoan, R., Ensoli, B. and Gallo, R.C.: Identification and culture of Kaposi’s sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls, Blood 84 (1994), 2711–2720.
Nickoloff, B.J. and Griffiths, C.E.M.: Factor XIIIa-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi’s sarcoma, Science 243 (1989), 1736–1737.
Boshoff, C., Whitby, D., Hatzioannou, T., Fisher, C., van der Walt, J., Hatzakis, A., Weiss, R.A. and Schulz, T.F.: Kaposi’s sarcoma-associated herpesvirus in HIV-negative Kaposi sarcoma, Lancet 345 (1995), 1043–1044.
Huang, Y.Q., Li, J.J., Kaplan, M.H., Poiesz, B.J., Katabira, E., Zhang, W.C., Feiner, D. and Friedman-Kien, A.: Human herpesvirus-like nucleic acid in various forms of Kaposi’s sarcoma, Lancet 345 (1995), 759–761.
Lebbé, C., de Cremoux, P., Rybojad, M., Costa da Cunha, C., Movel, P. and Calvo, F.: Kaposi’s sarcoma and new herpes virus, Lancet 345 (1995), 1180.
Moore, P.S. and Chang, Y.: Detection of herpesvirus-like DNA sequences in Kaposi’s sarcoma in patients with and without HIV infection New Engl. J. Med. 332 (1995), 1181–1185.
Buonaguoro, F.M., Tornesello, M.L., Beth-Giraldo, E., Hatzakis, A., Mueller, N., Downing, R., Biryamvaho, B., Sempala, D.K. and Giraldo, G.: Herpes virus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi’s sarcoma (KS) biopsies, Int. J. Cancer 65 (1996), 25— 28.
Schalling, M., Eukman, M., Kaaya, E.E., Linde, A. and Biberfeld, P.: A role for a new Herpesvirus (KSHV) in different forms of Kaposi’s sarcoma, Nature Med. 1 (1995), 707–708.
Decker, L.L., Shankar, P., Khan, G.: The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients, J. Exp. Med 184 (1996), 283–288.
Russo, J.J., Bohenzky, R.A., Chien, M.-C., Chen, J., Yan, M., Maddalena, D., Parry, J.P., Peruzzi, D., Edelman, I.S., Chang, Y. and Moore, P.S.: Nucleotide sequence of Kaposi’s sarcoma-associated herpesvirus (HHV 8) Proc. Natl. Acad. Sci. USA 93 (1996), 14862–14868.
Boshoff, C., Schulz, T.F., Kennedy, M.M., Graham, A.K., Fisher, C., Thomas, A., McGee, J.O., Weiss, R.A., and O’Leary, J.J.: Kaposi’s sarcoma-associated herpesvirus infects endothelial and spindle cells, Nature Med. 1 (1995), 1274–1278.
Staskus, K.A., Zhong, W., Gebhard, K., Hemdier, B., Wang, H., Renne, R., Beneke, J., Pudney, J., Anderson, D.J., Ganem, D. and Haase, A.T.: Kaposi’s sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells, J. Virol 71 (1997), 715–719.
Davis, M.A., Stürzl, M., Blasig, C., Schreier, A., Guo, H.G., Reitz, M., Opalenik, S.R. and Browning, P.J.: Expression of human herpesvirus 8-encoded cyclin D in Kaposi’s sarcoma spindle cells, J. Natl. Cancer Inst 89 (1997), 1868–1874.
Rainbow, L., Platt, G.M., Simpson, G.R., Sarid, R., Gao, S.-J., Stoiber, H., Herrington, C.S., Moore, P.S. and Schulz, T.F.: The 222–234 kd nuclear protein (LNA) of Kaposi’s sarcoma-associated herpesvirus (Human herpes virus 8) is encoded by orf73 and a component of the latency-associated nuclear antigen, J. Virol 71 (1997), 5915–5921.
Moore, P.S., Boshoff, C., Weiss, R.A. and Chang, Y.: Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV, Science 274 (1996), 1739–1744.
Orenstein, J.M., Alkan, S., Blauvelt, A., Jeang, K.-T., Weinstein, M.D., Ganem, D. and Hemdier, B.: Visualization of human herpesvirus type 8 in Kaposi’s sarcoma by light and transmission electron microscopy, AIDS 11 (1997), F35–745.
Dittmer, D., Lagunoff, M., Renne, R., et al.: A cluster of latently expressed genes in Kaposi’s sarcoma-associated herpesvirus, J. Virol 72 (1998), 8309–8315.
Chang,Y., Moore, P.S., Talbot, S.J., Boshoff, Zarkowska, C.T., Godden-Kent, D., Paterson, H., Weiss, R.A. and Mittnacht, S.: Cyclin encoded by KS herpesvirus, Nature 382 (1996), 410.
Thome, M., Schneider, P., Hofman, K., Fickenscher, H., Meinl, E., Neipel, F., Mattmann, C., Bums, K., Bodmer, J.-L., Schröter, M., Scaffidl, C., ‘Crammer, P.H., Peter, M.E. and Tschopp, J.: Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors, Nature 386 (1997), 517–521.
Godden-Kent, D., Talbot, S.J., Boshoff, C., Chang, Y., Moore, P.S., Weiss, R.A., and Mittnacht, S.: The cyclin encoded by Kaposi’s sarcoma-associated herpesvirus (KSHV) stimulates cdk6 to phoshorylate the retinoblastoma protein and Histone Hl, J. Virol 71 (1997), 4193–4198.
Li, M.T., Lee, H.R., Yoon, D.W., Albrecht, J.C., Fleckenstein, B., Neipel, F. and Jung, J.U.: Kaposi’s sarcoma-associated herpesvirus encodes a functional cyclin, J. Virol 71 (1997), 19841991.
Ellis, M., Chew, Y.P., Fallis, L., Freddersdorf, S., Boshoff, C., Weiss, R.A., Lu, X. and Mitmacht, S.: Degradation of p2714 cdk inhibitor triggered by Kaposi’s sarcoma virus cyclincdk6 complex, EMBO J. 18 (1999), 644–653
Mann, D.J., Child, E.S., Swanton, C., Laman, H. and Jones, N.: Modulation of p27wP’ levels by the cyclin encoded by Kaposi’s sarcoma-associated herpesvirus, EMBO J. 18 (1999), 654–663.
Swanton, C., Mann, D.J., Fleckenstein, B., Neipel, F., Peters, G. and Jones, N.: Herpes viral cyclin/cdk6 complexes evade inhibition by CDK inhibitor proteins, Nature 390 (1997), 184–187.
Zhong, W., Wang, H., Hemdier, B. and Ganem, D.: Restricted expression of Kaposi’s sarcoma- associated herpesvirus (human herpesvirus 8) genes in Kaposi’s sarcoma, Proc. Natl. Acad. Sci. USA 93 (1996), 6641–6646.
Muralidhar, S., Pumfery, A.M., Hassani, M., et al.: Identification of Kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus) transforming gene, J. Virol 72 (1998), 4980–4988.
Biberfeld, P., Ensoli, B., Sturzl, M., and Schulz, T.F.: Kaposi sarcoma-associated herpes- virus/human herpesvirus 8, cytokines, growth factors and HIV in the pathogenesis of Kaposi’s sarcoma, Curr. Opinion Inf. Dis 11 (1998), 97–105.
Boshoff, C., Endo, Y., Collins, P.D., Takeuchi, Y., Reeves, J.D., Schweickart, V.L., Siani, M.A., Sasaki, T., Williams, T.J., Gray, P.W., Moore, P.S., Chang, Y. and Weiss, R.A.: Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines, Science 278 (1997), 290–294.
Lee, H., Veazy, R., Williams, K., Li, M., Guo, J., Neipel, F., Fleckenstein, B., Lackner, A., Desrosiers, R.C. and Jung, J.U.: Deregulation of cell growth by the KI gene of Kaposiis sarcoma-associated herpesvirus, Nature Med. 4 (1998), 435–440.
Bais, C., Santomasso, B., Coso, O., Arvanitakis, L., Reaka, E.G., Gutkind, J.S., Asch, A.S., Cesarman, E., Gerhengom, M.C. and Mesri, E.A.: G-protein-coupled receptor of Kaposi’s sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator, Nature 341 (1998), 86–89.
Gao, S.J., Boshoff, C., Jayachandra, S., Weiss, R.A., Chang, Y. and Moore, P.S.: KSHV orf K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway, Oncogene 15 (1997), 1979–1985.
Lee, H., Guo, J., Li, M., Choi, J.-K., DeMaria, M., Rosenzweig, M. and Jung, J.U.: Identification of an immunoreceptor tyrosine-based activation motif of K1-transforming protein of Kaposi’s sarcoma-associated herpesvirus, Mol. Cell. Biol 18 (1998), 5219–5228.
Zimring, J.C., Goodboum, S. and Offermann, M.K.: Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1- mediated transcription, J. Virol 72 (1998), 701–707.
Sarid, R., Flore, O., Bohenzky, R.A., Chang, Y. and Moore, P.S.: Transcriptional mapping of the Kaposi’s sarcoma-associated herpesvirus (KSHV) genome in the body cavity-based lymphoma cell line BC-1, J. Virol 72 (1998), 1005–1012.
Flore, O., Rafii, S., Ely, S., O’Leary, J.J., Hyjek, E.M. and Cesarman, E.: Transformation of primary endothelial cells by Kaposi’s sarcoma-associated herpesvirus, Nature 394 (1998), 588592.
Conant, M.A., Opp, K.M., Poretz, D. and Mills, R.G.: Reduction of Kaposi’s sarcoma lesions following treatment of AIDS with ritonavir, AIDS 11 (1997), 1300–1301.
Blum, L., Pellet, C., Agbalika, F., Blanchard, G., Morel, P., Calvo, F. and Lebbé, C.: Complete remission of AIDS-related Kaposi’s sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy, AIDS 11 (1997), 1653–1655.
Murphy, M., Armstrong, D., Sepkowitz, K.A., Ahkami, R.N. and Myskowski, P.L.: Regression of AIDS-related Kaposi’s sarcoma following treatment with HIV-protease inhibitor, AIDS 11 (1997), 261–262.
Fiorelli, V., Gendelman, R., Samaniego, F., Markham, P.D. and Ensoli, B.: Cytokines from activated T-cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi’s sarcoma spindle cells, J. Clin. Invest 95 (1995), 1723–1734.
Ensoli, B., Gendelman, R., Markham, P., Fiorelli, V., Colombini, S., Raffeld, M., Cafaro, A., Chang, H.K., Brady, J.N. and Gallo, R.C.: Synergy between basic fibroblast growth factor and HIV-1 tat protein in induction of Kaposi’s sarcoma, Nature 371 (1994a), 674–680.
Samaniego, F., Markham, P.D., Gendelman, R., Gallo, R.C. and Ensoli, B.: Inflammatory cytokines induce endothelial cells to produce and release fibroblast growth factor and to promote Kaposi’s sarcoma-like lesions in nude mice, J. Immunol 158 (1997), 1887–1894.
Sirianni, M.C., Vincenzi, L., Fiorelli, V., Topino, S., Scala, E., Uccini, S., et al.: y-interferon production in peripheral blood mononuclear cells (PBMC) and tumour-infiltrating lymphocytes from Kaposi’s sarcoma patients: correlation with the presence of human herpesvirus-8 in PBMC and lesional macrophages, Blood 91 (1998), 968–976.
Fiorelli, V., Gendelman, R., Sirianni, M.C., Chang, H.K., Colombini, S., Markham, P.D. et al.: y-interferon produced by CD8’ T cells infiltrating Kaposi’s sarcoma induces spindle cells with angiogenic phenotype and synergy with HIV-1 Tat protein: an immune response to HHV-8 infection, Blood 91 (1998), 956–967.
Samaniego, F., Markham, P.D., Gendelman, R., Watanabe, Y., Kao, V., Kowalski, K., et al.: Vascular endothelial growth factor and basic fibroblast growth factor are expressed in Kaposi’s sarcoma and synergise to induce angiogenesis, vascular permeability and KS lesion development: induction by inflammatory cytokines, Am. J. Pathol 152 (1998), 1433–1443.
Chang, H.Q., Samaniego, F., Nair, B.C., Buonaguro, L. and Ensoli, B.: HIV-1 Tat protein exits from intact cells via a leaderless secretory pathway and binds extracellular matrix-associated heparan sulphate proteoglycans through its basic region, AIDS 11 (1997), 1421–1431.
Barillari, G., Fiorelli, V., Gendelman, R., Colombini, S., Samaniego, F., Morris, B.C., et al.: HIV-1 Tat protein enhances angiogenesis and Kaposi’s sarcoma (KS) development triggered by inflammatory cytokines (IC) or bFGF by engaging the v3 integrin, J. Acq. Immune Def. Syndr. Human Retrovir 114 (1997), A33.
Albini, A., Soldi, R., Giunciuglio, D., Giraudo, E., Benelli, R., Primo, L., et al.: The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells, Nature Med 2 (1996), 1371— 1375.
Lafrenie, R.M., Wahl, L.M., Epstein, J. S., Hewlett, I.K., Yamada, K.M., and Dhawan, S.: HIV-1 Tat protein promotes chemotaxis and invasive behaviour by monocytes, J. Immunol 157 (1996), 974–977.
Harrington, W., Sieczkowski, L., Sosa, C., Chan-a-Sue, S., Cai, J.P., Cabral, L. and Wood, C.: Activation of HI-IV-8 by HIV-1 Tat, Lancet 349 (1997), 774.
Rabkin, C.S., Janz, S., Lash, A., Coleman, A.E., Musaba, E., Liotta, L., et al.: Monoclonal origin of multicentric Kaposi’s sarcoma lesions, New Engl. J Med 336 (1997), 988–993.
Gill, P., Tsai, Y., Rao, A.P. and Jones, A.P.: Clonality in Kaposi’s sarcoma, New Engl. J. Med 337 (1997), 570–571.
Delabesse, E., Oksenhendler, E., Lebbé, C., Verola, O., Varet, B. and Turhan, A.G.: Molecular analysis of clonality in Kaposi’s sarcoma, J. Clin. Pathol 50 (1997), 664–668.
Schulz, T.F.: Epidemiology of Kaposi’s sarcoma-associated herpesvirus/ Human herpesvirus 8, Adv. Cancer Res,in press.
Boshoff, C. and Weiss, R.A.: Kaposi’s sarcoma—associated herpesvirus, Adv. Cancer Res 75 (1998), 57–86.
Olsen, S.J. and Moore, P.S.: Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV8) and the etiology of KS. In: Molecular Immunology of Herpesviruses,(H. Freidman, P. Medvecky and M. Bendinelli, eds.), New York: Plenum Press, 1999, in press.
Rabkin, C.S., Schulz, T.F., Whitby, D., Lennette, E.T., Magpanty, L.I., Chatlynne, L. and Biggar, R.J.: Interassay correlation of human herpesvirus 8 (HHV-8) serologic tests, J. Infect. Dis 178 (1998), 304–309.
Gao, S.J., Kingsley, L., Li, M., Zheng, W., Parravicini, C., Ziegler, J., Newton, R., Rinaldo, C.R., Saah, A., Phair, J., Detels, R., Chang, Y. and Moore, P.S.: Seroprevalence of KSHV antibodies among North Americans, Italians, and Ugandans with and without Kaposi’s sarcoma, Nature Med. 2 (1996b), 925–928.
Kedes, D.H., Operskalski, E., Busch, M., Kohn, R., Flood, J. and Ganem, D.: The seroprevalence of human herpesvirus 8 (HHV 8): Distribution of infection in Kaposi’s sarcoma risk groups and evidence for sexual transmission, Nature Med 2 (1996), 918–924.
Simpson, G.R., Schulz, T.F., Whitby, D., Cook, P.M., Boshoff, C., Rainbow, L., Howard, M.R., Gao, S.-J., Bohenzky, R.A., Simmonds, P., Lee, C., de Ruiter, A., Hatzakis, A., Tedder, R.S., Weller, I.V.D., Weiss, R.A. and Moore, P.S.: Prevalence of Kaposi’s sarcoma-associated herpes-virus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen, Lancet 348 (1996), 1133–1138.
Whitby, D., Luppi, M., Barozzi, P., Boshoff, C., Weiss, R. A. and Torelli, G.: Human herpesvirus 8 seroprevalence in blood donors and patients with lymphoma from different regions of Italy, J. Natl. Cancer Inst 90 (1998), 395–397.
Calabrd, M.L., Sheldon, J., Favero, A., Simpson, G.R., Fiore, J.R., Gomes, E., Angarano, G., Chieco-Bianchi, L. and Schulz, T.F.: Seroprevalence of Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV8) in different regions of Italy, J. Hum. Virol 1 (1998), 207–213.
Geddes, M., Franceschi, S., Barchielli, A., Falcini, F., Carli, S., Cocconi, G., Conti, E., Crosignani, P., Gafà, L., Giarelli, L., Vercelli, M. and Zanetti, R.: Kaposi’s sarcoma in Italy before and after the AIDS epidemic, Brit. J. Cancer 69 (1994), 333–336.
Cook, P.M., Whitby, D., Calabro, M.L., Luppi, M., Kakoola, D.N., Hjalgrim, H., Ariyoshi, K., Ensoli, B., Davison, A.J. and Schulz, T.F.: Variability and evolution of Kaposi’s sarcoma-associated herpesvirus in Europe and Africa, submitted for publication.
Mayama, S., Cuevas, L., Sheldon, J., Smith, D., Okong, P., Silvel, B. and Schulz, T.F.: Preva- lence of Kaposi’s sarcoma-associated herpesvirus (Human herpesvirus 8) in a young Ugandan population, /nt. J Cancer 77 (1998), 817–820.
Bourboulia, D., Whitby, D., Boshoff,C., et al.: Serologic evidence for mother-to-child transmission of Kaposi’s sarcoma—associated herpesvirus infection, JAMA 280 (1998), 31–32.
Bestetti, G., Renon, G., Mauclère, P., Ruffié, A., Mbopi Kéou, F.X., Eme, D., Parravicini, C., Corbellino, M., de Thé, G. and Gessain, A.: High seroprevalence of human herpesvirus-8 in pregnant women and prostitutes from Cameroon, AIDS 12 (1998), 541–543.
Nicholas, J., Zong, J., Alcendor, D.J., Ciufo, D., Poole, L.J., Sarisky, R.T., Chiou, C.J., Zhang, X., Wan, X., Guo, H.G., Reitz, M.S. and Hayward, G.S.: Novel organizational features, captured cellular genes and strain variability within the genome of KSHV/HHV8, Monogr. Natl. Cancer Inst 23 (1998), 79–88.
Zong, J.-C., Ciufo, D.M., Alcendor, D.J., Wan, X., Nicholas, J., Browning, P., Rady, P., Tyring, S.K., Orenstein, J., Rabkin, C., Su, I.-J., Powell, K.F., Croxson, M., Foreman, K.E., Nickoloff, B.J., Alkan, S. and Hayward, G.S.: High level variability in the ORF K1 membrane protein gene at the left end of the Kaposi’s sarcoma-associated herpesvirus (HHV 8) genome defines four major virus subtypes and multiple clades in different human populations, J. Virol., in press
Glenn, M.A., Rainbow, L., Auradé, F., Davison, A. and Schulz, T.F.: Identification of a spliced KSHV/HHV8 gene that encodes a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus, submitted for publication.
Melbye, M., Cook, P.M., Hjalgrim, H., Begtrup, K., Simpson, G.R., Biggar, R.J., Ebbesen, P. and Schulz, T.F.: Transmission of human herpesvirus 8 (HHV 8) among homosexual men follows the pattern of a ‘Kaposi’s sarcoma agent’, Int. J. Cancer 77 (1998), 543–548.
Renwick, N., Halaby, T., Weverling, G.J., Simpson, G.R., Coutinho, R.A., Lange, J.M.A., Schulz, T.F. and Goudsmit, J.: Seroconversion for Kaposi’s sarcoma-associated herpesvirus is highly predictive of KS development in HIV-1-infected individuals, AIDS 12 (1998), 24812488.
Martin, J.N., Ganem, D.E., Osmond, D.H., Page-Shafer, K.A., Macrae, D. and Kedes, D.H.: Sexual transmission and the natural history of human herpesvirus 8 infection, New Engl. J. Med 338 (1998), 948–954.
Dukers, N.H.T.M., Renwick, N., Prins, M., Geskus, R.B., Schulz, T.F., Weverling, G.-J., Coutinho, R.A. and Goudsmit, J.: Risk factors for HHV8 seropositivity and HHV8 seroconversion in a cohort of homosexual men, Am. J. Epidemiol, in press.
Ariyoshi, K., Schim van der Loeff, M., Corrah, T., Cham, F., Cook, P.M., Whitby, D., Weiss, R.A., Schulz, T.F. and Whittle, H.: Kaposi’s sarcoma and human herpesvirus 8 (HHV8) in HIV-1 and HIV-2 infection in The Gambia, J. Hum. Virol 1 (1998), 193–199.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Schulz, T.F. (2000). B — Pathogenesis of Kaposi’s Sarcoma. In: Schuitemaker, H., Miedema, F. (eds) AIDS Pathogenesis. Immunology and Medicine Series, vol 28. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0685-8_11
Download citation
DOI: https://doi.org/10.1007/978-94-017-0685-8_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5407-4
Online ISBN: 978-94-017-0685-8
eBook Packages: Springer Book Archive